Holen Sie sich die Stockscreener-App
93.98
0.53%
0.50
Handel nachbörslich:
94.63
0.65
+0.69%
Schlusskurs vom Vortag:
$93.48
Offen:
$93.01
24-Stunden-Volumen:
597.67K
Relative Volume:
0.87
Marktkapitalisierung:
$5.58B
Einnahmen:
$1.33B
Nettoeinkommen (Verlust:
$120.04M
KGV:
45.84
EPS:
2.05
Netto-Cashflow:
$172.71M
1W Leistung:
+0.77%
1M Leistung:
-1.10%
6M Leistung:
-2.83%
1J Leistung:
+9.74%
1-Tages-Spanne:
$92.27
$95.09
1-Wochen-Bereich:
$91.80
$95.09
52-Wochen-Spanne:
$82.62
$111.45
Merit Medical Systems Inc Stock (MMSI) Company Profile
Firmenname
Merit Medical Systems Inc
Sektor
Telefon
(801) 253-1600
Adresse
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Vergleichen Sie MMSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MMSI
Merit Medical Systems Inc
|
93.98 | 5.58B | 1.33B | 120.04M | 172.71M | 2.05 |
|
ISRG
Intuitive Surgical Inc
|
537.99 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.67 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.02 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.26 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.42 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-28 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-11 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-06-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-11 | Eingeleitet | CL King | Buy |
| 2024-02-07 | Eingeleitet | BofA Securities | Neutral |
| 2023-12-21 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-12-20 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2021-01-05 | Hochstufung | Needham | Hold → Buy |
| 2020-09-28 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-02-25 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-02-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-12-12 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-09-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-09-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Needham | Buy → Hold |
| 2019-07-26 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-10-02 | Bestätigt | Needham | Buy |
| 2018-08-07 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-07-24 | Bestätigt | Needham | Buy |
| 2018-06-01 | Bestätigt | Needham | Buy |
| 2018-05-18 | Bestätigt | SunTrust | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-04-20 | Eingeleitet | Needham | Buy |
| 2018-03-01 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-08-28 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-07-20 | Eingeleitet | BofA/Merrill | Buy |
| 2017-06-20 | Eingeleitet | SunTrust | Buy |
| 2017-04-05 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Merit Medical Systems Inc Aktie (MMSI) Neueste Nachrichten
Alcon and Merit Medical: Creating Regulatory and Quality Business Value with AI - Veeva
Vascular Access Devices Market to Hit US$9.05 Billion by 2030 with 7.1% CAGR | MarketsandMarkets™ - Barchart.com
Where are the Opportunities in (MMSI) - news.stocktradersdaily.com
Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - simplywall.st
Interventional Oncology Devices Market: Advanced Cancer - openPR.com
Merit Medical Systems CEO Fred Lampropoulos sells $38,244 in stock By Investing.com - Investing.com Nigeria
Merit Medical Systems CEO Fred Lampropoulos sells $38,244 in stock - Investing.com Australia
Merit Medical Systems (MMSI) Generated Positive Results from Margin Improvement Initiatives - Insider Monkey
Merit Medical Takes Over Biolife to Expand Post-Procedure Bleeding Control Portfolio - The Healthcare Technology Report.
Uterine Fibroid Treatment Devices Market Set to Witness - openPR.com
Insider Sell: Michael Mcdonnell Sells Shares of Merit Medical Sy - GuruFocus
President and CEO At Merit Medical Systems Sells $951K Of Stock - Nasdaq
Merit Medical Systems CEO Fred Lampropoulos sells $951,200 in stock By Investing.com - Investing.com Canada
Insider Sell: Michael Mcdonnell Sells Shares of Merit Medical Systems Inc (MMSI) - GuruFocus
Merit Medical Systems CEO sells $951,200 in stock By Investing.com - Investing.com South Africa
Merit Medical Systems CEO Fred Lampropoulos sells $951,200 in stock - Investing.com
Merit Medical Systems CEO sells $951,200 in stock - Investing.com
(MMSI) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Do Merit Medical Systems' (NASDAQ:MMSI) Earnings Warrant Your Attention? - Yahoo Finance
Have Merit Medical Systems Insiders Been Selling Stock? - simplywall.st
Merit Medical (MMSI) CEO Sells Significant Shareholding | MMSI S - GuruFocus
Merit Medical CEO sells $1.93M shares of shares - TipRanks
Merit Medical Systems CEO Fred Lampropoulos sells $1.93 million in stock - Investing.com
Merit Medical Systems CEO Fred Lampropoulos sells $1.93 million in stock By Investing.com - Investing.com South Africa
Q1 Earnings Highs And Lows: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Here's How Much $1000 Invested In Merit Medical Systems 20 Years Ago Would Be Worth Today - Benzinga
Prostatic Artery Embolization Market Set to Witness Rising AdoptionMerit Medical, Boston Scientific - openPR.com
When the Price of (MMSI) Talks, People Listen - news.stocktradersdaily.com
Merit Medical Systems (MMSI) Target Price Raised to $110 by Pipe - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Amidst Recent De - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Amidst Recent Developments | MMSI Stock News - GuruFocus
Canaccord Genuity Group Reiterates $112.00 Price Target for Merit Medical Systems (NASDAQ:MMSI) - Defense World
Merit Medical Systems acquires Biolife Delaware in $120 million deal - MSN
Merit Medical Systems: A Quality Business Judged On Its Merits (NASDAQ:MMSI) - Seeking Alpha
Canaccord raises Merit Medical price target to $112 By Investing.com - Investing.com South Africa
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio - sharewise
Canaccord raises Merit Medical price target to $112 - Investing.com Australia
MMSI: Target Price Raised by Canaccord Genuity with Buy Rating M - GuruFocus
Manatee medical manufacturer acquired for $120 million - Business Observer
Merit buys hemostatic device maker Biolife for $120M - MedTech Dive
Merit Medical Systems (MMSI) Target Price Increased by Wells Fargo | MMSI Stock News - GuruFocus
Merit Medical acquires Biolife Delaware - Medical Buyer
Risks To Shareholder Returns Are Elevated At These Prices For Merit Medical Systems, Inc. (NASDAQ:MMSI) - simplywall.st
Merit Medical (MMSI) Price Target Raised by Canaccord Analyst | - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Following Acquis - GuruFocus
Interventional Neuroradiology Market Growth, Trends & - openPR.com
Merit Medical acquires fellow interventional radiology vendor Biolife for $120M - Radiology Business
Finanzdaten der Merit Medical Systems Inc-Aktie (MMSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Merit Medical Systems Inc-Aktie (MMSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Parra Raul Jr. | CFO AND TREASURER |
Jun 13 '25 |
Sale |
93.75 |
15,181 |
1,423,219 |
24,201 |
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):